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bstract
Carvacrol is a main constituent in the essential oils of countless aromatic plants including Origanum  Vulgare  and Thymus  vulgari, which has
een assessed for substantial pharmacological properties. In recent years, notable research has been embarked on to establish the biological actions
f Carvacrol for its promising use in clinical applications. The present study is an attempt to reveal the protective role of Carvacrol against N-
itrosodiethylamine (DEN) induced hepatic injury in male Wistar albino rats. DEN is an egregious toxin, present in numerous environmental factors,
hich enhances chemical driven liver damage by inducing oxidative stress and cellular injury. Administration of DEN (200 mg/kg bodyweight,
.P) to rats results in elevated marker enzymes (in both serum and tissue). Carvacrol (15 mg/kg body weight) suppressed the elevation of marker
nzymes (in both serum and tissue) and augmented the antioxidants levels. The hoisted activities of Phase I enzymes and inferior activities of Phase
I enzymes were observed in DEN-administered animals, whereas Carvacrol treated animals showed improved near normal activity. Histological
bservations also support the protective role of Carvacrol against DEN induced liver damage. Final outcome from our findings intimate that
arvacrol might be beneficial in attenuating toxin induced liver damage.
 2015 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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m.  Introduction
Liver disease remains a critical health problem globally,
nduced by viruses, alcohol, lipid peroxidative products and vari-
us drugs [1]. Hepatic injury is a widespread common pathology
ketched by fibrosis that can end up in chronic hepatitis, cirrho-
is or cancer [2,3]. It has been well seasoned that oxidative stress
lays a causative role in the initiation, promotion and progres-
ion of hepatic diseases [4,5] and the liver is the main target
or several toxic agents that can reduce free radical-mediated
poptosis [6].
N-nitroso alkyl compounds, in particular DEN are an elo-
uent hepatotoxin, carcinogen and mutagen [7,8]. N-nitroso∗ Corresponding author at: Department of Biochemistry, Guindy Campus,
niversity of Madras, Chennai 600025, TN, India. Tel.: +91 044 2220 2731.
E-mail address: devakit@yahoo.co.uk (T. Devaki).
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213-4530/© 2015 Beijing Academy of Food Sciences. Production and hosting by Eompounds are considered to be a lethal, and they crop up in
obacco products, cheddar cheese, cured and browned meals,
ccupational surroundings, cosmetics, agricultural toxicants,
nd pharmaceutical agents [9,10]. DEN has been widely used as
 precursor in initiating carcinogenesis in experimental animal
odels [2,7]. Activation of DEN, which occurs chiefly in liver
icrosomes, has been demonstrated to stimulate Kupfer cells,
eading to high levels of ROS, capable of damaging liver cells
nd inducing hepatocarcinogenesis [11]. The cellular damage
aused by ROS is measured in terms of lipid peroxidation [12].
Essential oils and their constituents have been favorably
evered for their pharmaceutical actions. Plant-derived sub-
tances have in recent past turns out to be of great interest
wing to their multifaceted pharmacological activities [13]. Car-
acrol (2-methyl-5-(1-methylethyl)-phenol) (Fig. 1) is one such
onoterpene, a natural isopropyl hydroxytoluene known to pre-
ominantly occurs in essential oil of aromatic plants including
riganum Vulgare  (Oregano) and Thymus  vulgari  (Thyme),
hich has been assessed for substantial pharmacological prop-
rties [14]. Monoterpenoids explicit divergent exceptional
lsevier B.V. All rights reserved.
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2Fig. 1. Structure of Carvacrol.
iological effects like anti-oxidative, anti-inflammatory, and
ave preventive and therapeutic effects against many diseases
15]. Drugs and/or essential oils containing Carvacrol have been
xtensively used in traditional medicine, and a huge number
f feed additives based on this molecule are at present com-
ercially obtainable [16]. In addition, recent experimental data
ndicated that Carvacrol induces anxiolytic-like effect and anti-
epressant-like properties in tasks for anxiety and depression
ehavior in mice [17]. It is prominent that essential oils, which
re prolific in Carvacrol, bears rugged antioxidant character
dentical to those of ascorbic acid, butyl hydroxytoluene (BHT),
nd vitamin E [18] and can, truncate the risk of several degenera-
ive disorders [19]. Carvacrol also has a dynamic anti-microbial,
nti-fungal, and anti-inflammatory effect [20].
The present study was to embark upon the protective effect of
arvacrol against DEN-induced alterations on LPO and antioxi-
ant enzyme activities in rats during liver damage. Further serum
arker enzymes were also analyzed. Here, we report that Car-
acrol partly attenuates DEN-induced liver injury in rats via
nduction of antioxidant defense system.
.  Materials  and  methods
.1.  Source  of  chemicals
DEN and Carvacrol were purchased from Sigma Chemicals
o. (St. Louis, MO, USA). All other chemicals used were of
nalytical grade obtained from SRL/HIMEDIA, India.
.2.  Animals
Male, Wistar strain albino rats weighing about 170–180 g
ere obtained. The animals were housed in cages under proper
nvironmental conditions (26 ±  2 ◦C) and were fed with com-
ercial pelleted diet (M/S Hindustan Foods Ltd, Bangalore,
ndia). The animals had free access to water. All the experiments
ere designed and conducted according to the ethical norms
pproved by Institutional Animal Ethics Committee guidelines
IAEC No.04/02/2012).
.3.  Experimental  design  (Fig.  2)Group  I  Normal control rats, provided with standard diet and
rinking water.
Group II  Rats received drinking water for the first 13 days,
nd on day 14 and 28 a single dose of DEN (200 mg/kg body
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eight, intraperitoneally using saline) was given [21] and main-
ained for 42 days.
Group  III  Rats were treated with Carvacrol alone by orally,
lternative days in a week at a dose of 15 mg/kg body weight
based on effective dose fixation studies) for 4 weeks, serve as
rug control [22].
Group  IV  Rats were treated with Carvacrol (15 mg/kg body
eight) on alternative days to the DEN induced group of rats
rom day 14 till end of the experimental period.
At the end of the experimental period, the animals were
asted overnight and anesthetized with Xylazine (10 mg/kg) and
etamine (90 mg/kg) and sacrificed by cervical decapitation.
he blood was collected and allowed to coagulate at ambient
emperature for 30 min. Serum was separated by centrifugation
t 3000 r/min for 15 min at 4 ◦C. The liver was immediately sep-
rated and washed in ice-cold saline. The tissues were sliced
nd homogenized in 0.1 mol/L Tris–HCl buffer (pH 7.4). The
omogenates were centrifuged at 1000 r/min for 10 min at 4 ◦C
n a cooling centrifuge. The supernatants were separated and
sed for the determination of various parameters.
.4.  Biochemical  parameters
.4.1.  Fixation  of  optimum  dosage  schedule
The suitable optimum dosage of Carvacrol was found
y treating various doses of Carvacrol (10 mg/kg, 15 mg/kg,
0 mg/kg and 45 mg/kg body weight of rat) orally to the DEN
nduced group of rats. Carvacrol dose for a maximum efficacy
n the minimum dose was determined as elicited by the lev-
ls of serum marker enzymes for tissue damage. At the end of
xperimental period, the animals were sacrificed and the serum
eparated was used to assess the biochemical changes. The
osage that gives the maximum protective efficacy (as elicited
y the activities of AST, ALT, LDH and GGT in the serum) was
xed up as the optimum dosage for the drug. It was found that
5 mg/kg body weight of Carvacrol had the maximum protec-
ive efficacy in the minimum dosage. This dose of Carvacrol was
ollowed for all the experimental studies (Fig. 3).
.4.2. Estimation  of  marker  enzymes
Activities of aspartate transaminases (AST) [23], alanine
ransaminases (ALT) [23], lactate dehydrogenase (LDH) [24],
lkaline phosphatase (ALP) [25], 5′-Nucleotidase (5′NT) [26]
nd -glutamyl transpeptidase (GGT) [27] were estimated in
erum samples.
.4.3. Estimation  of  macromolecular  damages
.4.3.1. Assay  of  lipid  peroxidation  (LPO).  Malondialdehyde
MDA) level, the main product of lipid peroxidation was deter-
ined as described by Ohkawa et al., 1979 [28]. MDA is defined
s nmol per mg of protein.
.4.3.2.  Estimation  of  enzymic  and  non-enzymic  antioxidants.
nzymatic antioxidant such as superoxide dismutase (SOD)
29], catalase (CAT) [30], glutathione peroxidase (Gpx) [31],
lutathione reductase (GR) and Non-enzymic antioxidant such
s glucose-6-phosphate dehydrogenase (G6PD) [32], vitamin
68 B. Rajan et al. / Food Science and Human Wellness 4 (2015) 66–74
Fig. 2. Schematic representation of the experimental design used for the study.
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 (VIT C) [33], vitamin E (VIT E) [34], vitamin A (VIT A)
35] and glutathione (GSH) [36] content were assayed in tissue
omogenate.
.4.3.3.  Estimation  of  Phase  I  and  Phase  II  drug  metabo-
izing enzymes.  Phase I drug metabolizing enzymes such as
ytochrome P450 (CYTP 450) [37], Cytochrome b5 (CYTB5)
37], Cytochrome P450 reductase (CYTP 450 RED) [37],
ytochrome b5 reductase (CYTB5 RED) [38] and Phase II drug
etabolizing enzymes like glutathione S-Transferase (GST)
39] and UDP Glucuronyl Transferase (UDP-GT) [40] were also
nalyzed in tissue homogenate.
P
Pl groups of rats. Results are expressed as mean ± S.D. for six rats in each group.
.5.  Histological  evaluation
Histological evaluation was performed on a portion of the
iver tissue after fixation with 10% formalin, embedded in paraf-
n wax, sectioned were stained with hematoxylin and eosin to
ssess the pathological changes.
.6.  Statistical  analysisThe results were computed statistically (SPSS/10 Software
ackage; SPSS Inc., Chicago, IL, USA) using one-way ANOVA.
ost hoc testing was performed for inter comparisons using the
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Fig. 4. Effect of Carvacrol on food consumption of control and experimental
groups of rats. Results are expressed as mean ± S.D. for six rats in each group.
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Fig. 6. Effect of Carvacrol on Liver weight and Relative weight of control and
experimental groups of rats. Results are expressed as mean ± S.D. for six rats in
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gtatistical significance at p < 0.05 compared with a Compared with group 1 and
Compared with group 2.
SD. In all tests, the level of statistical significance was set at
 < 0.05.
.  Results
.1.  Effect  of  Carvacrol  on  food  consumption,  body  weight,
iver weight  and  relative  liver  weight
The hepatoprotective effect of Carvacrol against DEN-
nduced liver injury was elucidated in male Wistar albino rats.
ig. 4 shows the food consumption of normal and induced rats,
here is no notable decline in the food intake in induced rats
hen compared to normal rats. Figs. 5 and 6 show Initial body
eight, Final body weight, Liver weight and relative liver weight
g/100 g body weight) of control and experimental group of ani-
als. In DEN-induced group 2 animals, there is a significant
ig. 5. Effect of Carvacrol on Initial body weight and final body weight of
ontrol and experimental groups of rats. Results are expressed as mean ± S.D.
or six rats in each group. Statistical significance at p < 0.05 compared with a
ompared with group 1 and b Compared with group 2.
3
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bach group. Statistical significance at p < 0.05 compared with a Compared with
roup 1 and b Compared with group 2.
ecrease in the final body weight and significant increase in
iver weight when compared with group 1 control animals. The
arvacrol treated group 4 showed a significant increase in the
nal body weight when compared with group 2 animals.
During the course of the experiment, all rats showed the
reater tolerance to treatment with Carvacrol. In group 2 ani-
als, the relative liver weight significantly increased when
ompared with group 1 animals and there is a significant
ecrease in the liver weight in Carvacrol treated groups 4 ani-
als when compared with group 2 animals. No obvious changes
ere observed between the control and Carvacrol alone treated
roup which is an indicative of nontoxic nature of Carvacrol.
.2.  Carvacrol  attenuates  lipid  peroxidationFig. 7 shows the level of LPO in the serum and liver of con-
rol and experimental groups of animals which was analyzed for
ig. 7. Effect of Carvacrol on Lipid Peroxidation in control and experimental
roups of rats. Results are expressed as mean ± S.D. for six rats in each group.
tatistical significance at p < 0.05 compared with a Compared with group 1 and
Compared with group 2.
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Table 1
Effect of Carvacrol on the activities of marker enzymes in the serum of control and experimental groups of rats.
Particulars Group 1 (Control) Group 2 (Induced) Group 3 (Drug control) Group 4 (Treated)
AST 112.08 ± 8.95 234.34 ± 16.89a 112.19 ± 8.82 165.53 ± 11.86b
ALT 33.07 ± 2.52 79.32 ± 6.53a 33.09 ± 2.47 48.59 ± 4.38b
ALP 33.12 ± 3.05 68.48 ± 4.28a 32.09 ± 2.96 43.93 ± 4.10b
LDH 78.36 ± 4.98 113.76 ± 9.04a 78.29 ± 4.94 101.23 ± 7.54b
GGT 6.07 ± 0.35 11.25 ± 1.04a 6.03 ± 0.36 8.96 ± 0.78b
5′NT 3.09 ± 0.29 6.40 ± 0.53a 3.05 ± 0.31 4.56 ± 0.39b
Results are expressed as mean ± S.D. for six rats in each group. Statistical significance at p < 0.05 compared with a Compared with group 1 and b Compared with
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Aroup 2.
ctivity is expressed as IU/L for AST, ALT, ALP, LDH, GGT and 5′NT.
xidative stress. In DEN-induced group 2 animals, there is a sig-
ificant increase in the levels of lipid peroxides when compared
ith group 1 normal control animals. Whereas in Carvacrol
reated groups 4 animals, there is a significant decrease in the
evels of lipid peroxides when compared with group 2 induced
nimals. However, animals treated with Carvacrol alone (group
) did not show any significant changes when compared with
roup 1 control animals.
.3.  Effect  of  Carvacrol  on  the  activities  of  marker  enzymes
Tables 1 and 2 portray the effect of Carvacrol on the activities
f marker enzymes AST, ALT, ALP, LDH, GGT and 5′NT in the
erum and liver of control and experimental group of rats. These
arker enzymes are significantly (p  < 0.05) increased in DEN-
nduced group 2 animals when compared with group 1 normal
ontrol animals. Carvacrol-treated groups 4 showed a significant
ecrease in the activities of these enzymes when compared with
roup 2 DEN-induced animals. This may prove that Carvacrol
as better restoration potential of liver tissue.
.4.  Evaluation  of  antioxidant  status  in  liver
Table 3 depicts the antioxidant status in the liver of con-
rol and experimental group of animals. DEN-induced group
 animals exhibited a significant decrease in the activities of
OD and CAT when compared with group 1 normal control ani-
als, Carvacrol-treated groups 4 showed a significant increase
n the activities of SOD and CAT when compared with group 2
EN-induced animals. The activities of GPx, GR, GSH, G6PD,
IT A, VIT C and VIT E also significantly decreased in DEN
m
m
able 2
ffect of Carvacrol on the activities of marker enzymes in the liver of control and exp
articulars Group 1 (Control) Group 2 (Induced) 
ST 125.63 ± 9.87 372.26 ± 30.70a
LT 46.23 ± 3.63 141.27 ± 12.76a
LP 50.48 ± 3.87 106.68 ± 9.99a
DH 74.23 ± 5.83 183.86 ± 16.99a
GT 16.97 ± 1.33 32.79 ± 2.88a
′NT 87.86 ± 6.55 196.24 ± 16.28a
esults are expressed as mean ± S.D. for six rats in each group. Statistical significan
roup 2.
ctivity is expressed as IU/L for AST, ALT, ALP, LDH, GGT and 5′NT.nduced group 2 animals when compared with group 1 control
nimals. In Carvacrol-treated groups 4 animals, there is a signif-
cant increase in the activities of GPx, GR, GSH, G6PD, VIT A,
IT C and VIT E when compared with group 2 DEN-induced
nimals. No adverse effect was observed in group 3 animals.
his clearly proves the antioxidant capacity of Carvacrol due to
ts free radical encountering activity.
.5.  Evaluation  of  Phase  I and  Phase  II  drug  metabolizing
nzymes
Table 4 portrays the effect of Carvacrol on the activities of
hase I and Phase II drug metabolizing enzymes in the liver
f control and experimental group of rats. CYTP450, CYTB5,
YTP450 REDUCTASE, CYTB5 REDUCTASE enzymes are
ignificantly (p  < 0.05) increased in DEN-induced group 2 ani-
als when compared with group 1 normal control animals.
arvacrol-treated groups 4 showed a significant decrease in
he activities of these enzymes when compared with group 2
EN-induced animals. Whereas GST and UDP-GT enzymes are
ignificantly (p  < 0.05) decreased in DEN-induced group 2 ani-
als when compared with group 1 normal control animals. Upon
arvacrol treatment groups 4 showed a significant increase in the
ctivities of these enzymes. This clearly reveals that Carvacrol
as maximum renovation potential of liver tissue.
.6.  Effect  of  Carvacrol  on  histological  features  of  liverThe histology of the liver tissue was examined under a light
icroscope. Group 1 control animals (Fig. 8a) revealed the nor-
al architecture of the liver cells with granulated cytoplasm
erimental groups of rats.
Group 3 (Drug control) Group 4 (Treated)
126.24 ± 9.86 247.69 ± 21.31b
46.38 ± 3.64 104.82 ± 9.90b
50.76 ± 4.03 89.57 ± 8.11b
75.03 ± 5.90 135.47 ± 12.13b
16.21 ± 1.28 27.08 ± 2.24b
88.21 ± 6.54 175.27 ± 14.19b
ce at p < 0.05 compared with a Compared with group 1 and b Compared with
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Table 3
Effect of Carvacrol on the activities of antioxidant enzymes in the liver of control and experimental groups of rats.
Particulars Group 1 (Control) Group 2 (Induced) Group 3 (Drug control) Group 4 (Treated)
SOD 8.18 ± 0.59 4.36 ± 0.46a 8.22 ± 0.62 6.92 ± 0.49b
CAT 68.62 ± 4.94 38.82 ± 3.46a 68.47 ± 4.98 58.74 ± 4.46b
GPX 99.23 ± 6.25 59.23 ± 5.56a 99.95 ± 6.25 86.41 ± 5.80b
GR 164.96 ± 8.90 103.72 ± 9.59a 165.20 ± 8.88 145.96 ± 9.08b
GSH 44.32 ± 3.38 17.65 ± 1.9a 44.29 ± 3.39 34.39 ± 2.66b
G6PD 7.19 ± 0.45 3.49 ± 0.24a 7.21 ± 0.47 5.02 ± 0.34b
VITAMIN C 3.75 ± 0.23 1.45 ± 0.05a 3.78 ± 0.24 2.85 ± 0.16b
VITAMIN A 3.43 ± 0.21 1.79 ± 0.07a 3.40 ± 0.20 2.45 ± 0.10b
VITAMIN E 5.89 ± 0.37 2.01 ± 0.11a 5.90 ± 0.36 3.76 ± 0.22b
Results are expressed as mean ± S.D. for six rats in each group. Statistical significance at p < 0.05 compared with a Compared with group 1 and b Compared with
group 2.
Units: SOD superoxide dismutase in units/mg protein, CAT catalase in mol of H2O2 decomposed/min/mg protein, GSH glutathione in lg/mg protein, GPx glutathione
peroxidase in mol of GSH utilized/min/mg protein, GR glutathione reductase in mol of NADPH oxidized/min/mg protein, Vit C in mg/g of wet tissue, Vit D in
mg/g of wet tissue and Vit E in mg/g of wet tissue.
Table 4
Effect of Carvacrol on the activities of Phase I and Phase II drug metabolizing enzymes in the liver of control and experimental groups of rats.
Particulars Group 1 (Control) Group 2 (Induced) Group 3 (Drug control) Group 4 (Treated)
CYTP450 0.76 ± 0.05 1.43 ± 0.12a 0.74 ± 0.05 1.20 ± 0.10b
CYTB5 0.49 ± 0.03 1.09 ± 0.08a 0.50 ± 0.09 0.85 ± 0.06b
CYTP450 REDUCTASE 5.89 ± 0.36 10.33 ± 0.85a 5.88 ± 0.35 8.58 ± 0.69b
CYTB5 REDUCTASE 5.86 ± 0.36 9.87 ± 0.82a 5.83 ± 0.35 8.99 ± 0.74b
GST 6.79 ± 0.46 1.02 ± 0.09a 6.76 ± 0.45 4.98 ± 0.44b
UDP-GT 9.87 ± 0.68 3.57 ± 0.46a 9.85 ± 0.69 5.26 ± 0.43b
Results are expressed as mean ± S.D. for six rats in each group. Statistical significance at p < 0.05 compared with a Compared with group 1 and b Compared with
group 2.
Units are expressed as nmoles/mg of protein for cytochrome p450 and cytochrome b5; nmoles of Cyt c oxidized/min/mg of protein for NADPH Cyt p450 reductase;
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nd small uniform nuclei, and group 3 animals (drug control;
ig. 8c) also showed the normal histological appearance of liver
ells indicating the nontoxic nature of Carvacrol. The group
 animals induced with DEN (Fig. 8b) depicted the area of
epatocellular necrosis with the adjacent liver cells exhibit-
ng dysplastic changes, and the animals treated with Carvacrol
Fig. 8d) showed no necrosis with a decrease in hepatic damage.
.  Discussion
DEN has been reported to induce a relentless generation of
ree radicals in the liver, which in turn augment the demand of
ntioxidant enzymes. Subsequently, it ends in oxidative stress
nd initiation of carcinogenesis. Single dose of DEN injection on
4th and 28th day reduced body weight and noticeably increased
he ratio of liver to overall body weight in comparison with nor-
al rat. Depletion in food intake and therefore, the reduction of
ody weight gain noticed in DEN-treated animals, could be pre-
ominantly due to loss from skeletal muscle and adipose tissue
s already shown, and it could be considered as an ancillary indi-
ation of the diminishing hepatic function following exposure
o DEN. In addition, evaluation of the liver/body weights ratio
as used to scrutinize potential changes in the liver size, but
o changes were found. In the present investigation, the hoisted
evels of marker enzyme in serum and liver are determinations of
l
t
eDNB conjugated/min/mg protein for Glutathione-S-transferase; Units/min/mg
ellular damage and loss of functional integrity of the cell mem-
rane due to DEN administration. Treatment with Carvacrol
15 mg/kg) brought back these enzymes to near routine level by
ossibly preserving the functional integrity of the hepatocytes,
howing its defense action against DEN induced Hepatotoxicity.
t was already reported that, the dosage of 25 mg/kg bodyweight
f Carvacrol pretreatment resulted in the protection against
hioacetamide-induced liver toxicity by attenuation of oxida-
ive stress, inflammation, and apoptosis [41]. Though, previous
tudies by Nafees et al., showed 25 mg/kg body weight of Car-
acrol as a maximum protective dose, our studies suggesting that
ven 30 mg/kg body weight of Carvacrol had similar protective
ffective as like in 15 mg/kg bodyweight of Carvacrol (based
n dosage fixation study in figure). So we fixed up a dose of
5 mg/kg body weight of Carvacrol as a maximum efficacy with
inimum dosage and we used this concentration as standard
oncentration for further experimental studies. GR plays a key
ole in cellular defense against oxidative stress by arresting accu-
ulation of GSSG and thus maintaining the redox state. The
ecreased level of GR activity after DEN administration possi-
ly reflects conformity to oxidative conditions. The reduction in
he specific activities of antioxidant enzymes and drug metabo-
izing enzyme, after DEN administration may be associated to
heir inhibition by DEN through immediate interaction with the
nzyme molecules or modification of the post-transcriptional
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nd post-translational steps in the enzyme synthesis. DEN, an
ndirect acting carcinogen that requires metabolic activation to
ield an ultimate carcinogen. It is widely accepted that metabolic
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enic injury occurs in the presence of Phase II drug metabolizing
nzymes. One of the important pathways is GSH conjuga-
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roximate and ultimate carcinogens through formation of more
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ST and UDP-GT enzymes are significantly decreased in liver
njured animals when compared with normal control animals,
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ant increase in the activities of these enzymes. A significant
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lose cholestasis and bile duct necrosis. As DEN causes liver
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o control rats (Tables 1 and 2). On the other hand, the activ-
ties of these marker enzymes were significantly decreased in
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 animals. Administration of DEN has been described to gener-
te more LPO products like Malondialdehyde. Such discovery
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PO in DEN-treated rats (Fig. 7), which was significantly low-
red on Carvacrol treatment. Natural antioxidants are capable of
reventing ROS production, and thereby, it detracts the intracel-
ular oxidative stress. GSH is an important naturally occurring
ellular non-enzymatic antioxidant and is needed to maintain
he normal reduced state of the cells and to counteract ROS
hereby reducing the oxidative stress. GSH depletion ultimately
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ncing functional and structural coherence of cell and organelle
embrane. The Carvacrol treated rats administered with DEN
howed significant raise in the levels of hepatic GSH when com-
ared to DEN-treated animals (Table 3). This increase in GSH
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xtremity of the oxidative stress-induced during the exposure to
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